Daraxonrasib Resets Pancreatic Cancer Math; SoftBank Bets Big on French Compute; Palo Alto Bug Hits Live Networks
The dominant story is daraxonrasib, a pancreatic cancer pill whose phase 3 data put a hard number on a field…
The dominant story is daraxonrasib, a pancreatic cancer pill whose phase 3 data put a hard number on a field…
The cleanest story today is Mistral on-prem AI. While the model race still gets the attention, the harder commercial signal…
ByteDance chips are the clearest signal today, even if the clearest fact is still that the company has not confirmed…
A local LLM is not one product. It is a stack: model weights, a file format, an inference engine, a…
The big move in YouTube AI labels is not the box. It is YouTube AI labels becoming something the platform…
The sharpest story today is PostHog customer data, because it spells out a trend vendors usually leave implied. Elsewhere, the…
The clearest signal today is not a new model benchmark, but AI coding economics getting less polite. Between DeepSeek’s 75%…
Canva has lost four senior leaders in the same month as it pushes harder to remake itself around AI features,…
The sharpest story today is Heretic, because it turns model safety from a lab policy into a forkable artifact. Elsewhere,…